Full-Time

Senior Process Engineer

Deadline 7/14/27
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

1,001-5,000 employees

Integrated design, engineering, construction management

No salary listed

Vaughan, ON, Canada

In Person

Requires 5–20% travel, client-site assignments, and routine travel or commuting; reliable transportation is required.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Process Engineering
AutoCAD

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Requirements
  • 10+ years of engineering experience and 5+ years of process design experience, preferably in the pharmaceutical and biotechnology industries.
  • A Bachelor’s Degree in Chemical Engineering.
  • Knowledge of current Good Manufacturing Practices (cGMPs) as they affect process design and equipment specification.
  • Ability to stand, sit, and walk for prolonged periods.
  • Ability to stoop, kneel, crouch, and crawl as required.
  • Ability to lift and move objects weighing up to 25 pounds.
  • Ability to climb ladders as necessary.
  • Ability to work in indoor and outdoor environments with varying working conditions.
  • Ability to adhere to strict cleanroom gowning protocol.
  • Ability to travel and commute on a daily or routine basis.
  • Access to reliable transportation.
  • Ability to follow stated client-site safety rules.
  • Ability to work in a safety-sensitive, field-based position at client sites.
Responsibilities
  • Assist the Lead Process Engineer with conceptual design deliverables, including Process Flow Diagrams and Material and Energy Balances.
  • Estimate utility requirements for new manufacturing processes and design utility generation and distribution systems.
  • Generate Process Piping and Instrumentation Diagrams (P&IDs), preferably using AutoCAD, including control strategies and Clean-in-Place (CIP)/Steam-in-Place (SIP) functions when appropriate.
  • Generate P&IDs for critical utility systems, including Water for Injection (WFI), United States Pharmacopeia (USP) Purified Water, and Clean Steam.
  • Perform engineering studies for expanding, improving, or automating existing facilities with limited supervision.
  • Produce specifications and performance data sheets for process equipment and instrumentation.
  • Use and participate in developing company design and production tools, including process simulation and smart P&IDs.
  • Own the process-related aspects of a portion of a large project or an entire small project and provide technical support to the design team.
  • Establish and maintain working relationships with clients and IPS design-team members.
  • Visit client sites and comply with their stated safety rules.
  • Complete special projects as assigned.
Desired Qualifications
  • Process design and operations experience in pharmaceutical facilities, including biologic, vaccine, active pharmaceutical ingredient (API) organic synthesis, oral solid dosage (OSD), and parenteral aseptic drug products.
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

View

IPS provides design, engineering, and construction management for complex facilities, especially in the pharmaceutical and biotech industries. Its products work by integrating these services into one team from the project’s start, coordinating planning, detailed design, procurement, and construction management to align with a client's business goals and move a project from concept to operational facility. The company differentiates itself through integrated delivery across disciplines and a global footprint (five continents), supported by growth through strategic acquisitions and Berkshire Hathaway backing, which adds financial strength and scale. IPS’s goal is to help life-science clients bring critical facilities online efficiently, with predictable cost, schedule, and quality, by delivering coordinated design, engineering, and construction management under one umbrella.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Philadelphia, Pennsylvania

Founded

1989

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GE HealthCare named IPS lead on its Cork expansion on January 31, 2025.
  • BeiGene's $800 million Hopewell facility completed in January 2025, proving delivery at scale.
  • Revelio Labs showed 7,131 employees in March 2026, with 561 active postings across the business.

What critics are saying

  • Kinetic System v. IPS ended with adverse fee rulings on March 24, 2025, exposing contract friction.
  • IPS remains tied to capital-intensive drug plants; project cancellations quickly crush utilization and margin.
  • If biotech capex freezes through 2026, IPS loses backlog concentration and Berkshire owns a cyclical builder.

What makes IPS-Integrated Project Services, LLC unique

  • IPS integrates EPCMV across pharma and biotech, from concept through final process qualification.
  • Berkshire Hathaway ownership since 2022 gives IPS permanent capital and credibility with large customers.
  • IPS runs 29 offices across 22 countries, supporting global delivery for regulated facilities.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
PR Newswire
Aug 8th, 2025
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer

TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.

IPSDB
Mar 14th, 2025
IPS Expands Leadership in Ireland with Appointment of Karl Page

IPS expands leadership in Ireland with appointment of Karl Page.

HIT Consultant
Feb 25th, 2025
The Future Of Advanced Therapeutics: Opportunities And Challenges

Sai Bhamidipati, Pharmaceutical Regulatory Affairs ConsultantThe biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.mRNA Vaccines: Revolutionizing Disease PreventionMessenger RNA (mRNA) vaccines have gained prominence, particularly during the COVID-19 pandemic, demonstrating the potential for rapid development and high efficacy. Unlike traditional vaccines, which utilize weakened or inactivated pathogens or their protein subunits, mRNA vaccines utilize a synthetic version of the messenger RNA to instruct cells to produce a protein that elicits an immune response. This modality allows for swift adaptation to emerging pathogens and has opened avenues for vaccines targeting various diseases, including influenza and certain types of cancers.Opportunities:Rapid Development: The cell-free, scalable nature of mRNA production enables quick responses to emerging health threats.IPSDBThe cell-free, scalable nature of mRNA production enables quick responses to emerging health threats. IPSDB Versatility: mRNA vaccines can be designed to target a wide range of therapeutic areas, including but not limited to infectious diseases, Cancer-specific antigens, and rare disease areas.Challenges:Manufacturing Complexities: Scaling up production for mass production while maintaining quality and consistency poses significant challenges

IPSDB
Sep 18th, 2024
Kneat and IPS Announce Strategic Partnership

By integrating Kneat's digital validation software with IPS' technology driven delivery approach, a new benchmark for a truly digital integrated project delivery model, from concept/requirements definition through final process qualification.

IPSDB
Jul 11th, 2024
IPS Accelerates Expansion in Switzerland with New Office and Enhanced R&D Capabilities

Additionally, Integrated Project Services, LLC is excited to announce the appointment of Pia Mueller as the new Senior Manager of Laboratory Projects.